Active Specific Immunotherapy (ASI) and Gcmaf Forte in Management of Metastatic Invasive Carcinoma–Overview of the Therapeutic Modalities and a Case Report

Journal of Clinical & Experimental Immunology
doi 10.33140/jcei/03/02/00003
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Opast Group LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy